Patent · US Active

Method for altering drug pharmacokinetics based on medical delivery platform

US9242052B2 · kind B2 · utility

5Cited by

62References

20Claims

0Family size

Assignee

Becton, Dickinson and Company · US

Inventors

Ronald J. Pettis · Durham, US
Noel G. Harvey · Efland, US
James A. Down · Cary, US

Key dates

Filing date	Mar 17, 2014
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Mar 17, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2037/0061
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for directly delivering whereby a substance is introduced into an intradermal space within mammalian skin which involves administering the substance through at least one small gauge hollow needle having an outlet with an exposed height between 0 and 1 mm. The outlet is inserted into the skin to a depth of between 0.3 mm and 2 mm such that the delivery of the substance occurs at a depth between 0.3 mm and 2 mm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.